After some further research, I noticed that Chaslav Radovich has been able to obtain funding with a previous company he was CEO of called BioGentech, in the tune of $3.2 million. Good to know that if CTDT hasn't already obtained funding through whatever transaction took place, they have someone who has done this in the past. GO CTDT!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.